GE HealthCare Technologies Inc. (NASDAQ:GEHC) Given Average Recommendation of “Hold” by Brokerages

GE HealthCare Technologies Inc. (NASDAQ:GEHC) has been assigned an average recommendation of “Hold” from the fourteen research firms that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $92.50.

GEHC has been the subject of a number of recent analyst reports. Jefferies Financial Group upped their price target on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a report on Thursday, December 11th. Citigroup boosted their price objective on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the company a “neutral” rating in a research report on Thursday, December 11th. The Goldman Sachs Group restated a “buy” rating and set a $98.00 target price on shares of GE HealthCare Technologies in a research note on Friday, January 9th. Piper Sandler lifted their price target on GE HealthCare Technologies from $91.00 to $94.00 and gave the company an “overweight” rating in a research note on Friday, January 30th. Finally, UBS Group downgraded GE HealthCare Technologies from a “neutral” rating to a “sell” rating and upped their price objective for the stock from $73.00 to $77.00 in a research report on Thursday, January 15th.

Institutional Trading of GE HealthCare Technologies

Hedge funds have recently added to or reduced their stakes in the stock. Wedge Capital Management L L P NC acquired a new stake in GE HealthCare Technologies during the third quarter worth approximately $26,859,000. Valicenti Advisory Services Inc. boosted its holdings in shares of GE HealthCare Technologies by 22.6% during the 3rd quarter. Valicenti Advisory Services Inc. now owns 68,107 shares of the company’s stock worth $5,115,000 after buying an additional 12,550 shares in the last quarter. Locust Wood Capital Advisers LLC grew its position in shares of GE HealthCare Technologies by 7.1% during the 3rd quarter. Locust Wood Capital Advisers LLC now owns 2,084,337 shares of the company’s stock worth $156,534,000 after buying an additional 137,992 shares during the period. National Bank of Canada FI grew its position in shares of GE HealthCare Technologies by 133.3% during the 2nd quarter. National Bank of Canada FI now owns 899,693 shares of the company’s stock worth $66,640,000 after buying an additional 514,007 shares during the period. Finally, Nan Fung Trinity HK Ltd. bought a new stake in shares of GE HealthCare Technologies in the 3rd quarter valued at $23,206,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 2.0%

Shares of GEHC stock opened at $80.65 on Friday. The stock has a market cap of $36.76 billion, a P/E ratio of 17.69, a price-to-earnings-growth ratio of 2.43 and a beta of 1.08. GE HealthCare Technologies has a 1 year low of $57.65 and a 1 year high of $94.80. The company has a current ratio of 1.37, a quick ratio of 0.95 and a debt-to-equity ratio of 0.91. The stock has a 50 day simple moving average of $82.73 and a 200 day simple moving average of $77.54.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.04. The company had revenue of $5.70 billion for the quarter, compared to analyst estimates of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.GE HealthCare Technologies’s quarterly revenue was up 7.1% on a year-over-year basis. During the same period in the prior year, the firm posted $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, research analysts predict that GE HealthCare Technologies will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Friday, January 9th will be paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, January 9th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 2.89%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.